Aridis Pharmaceuticals Inc

+0.20 (+9.66%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)31.90M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$3.6 Million
Adjusted EPS-$0.50
See more estimates
10-Day MA$2.28
50-Day MA$3.09
200-Day MA$5.02
See more pivots

Aridis Pharmaceuticals Inc Stock, NASDAQ:ARDS

983 University Avenue, Building B, Los Gatos, California 95032
United States of America
Phone: +1.408.385.1742
Number of Employees: 33


Aridis Pharmaceuticals, Inc. engages in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections. Its products include AR-301, AR-101, AR-501, AR-712, AR-701, AR-401, AR-105 and AR-201. The company was founded by Eric J. Patzer and Vu L. Truong in 2003 and is headquartered in Los Gatos, CA.